DePuy Synthes was granted FDA 510(k) clearance to market the TELIGENâ„¢ System, an integrated technology platform that supports minimally invasive surgical transforaminal lumbar interbody fusion (MIS-TLIF) procedures through digital tools for visualization and access.
TELIGEN will be available in the U.S. later this year.
TELIGEN comprises a tower that delivers a suite of technologies, including camera control, a VueLIF-Tâ„¢ Procedure Kit with disposable HD camera, a TELIGEN Clear Discectomy Device and patient-based disposable ports. TELIGEN integrates with the UNLEASHâ„¢ bundle of implants, which is designed to streamline the main stages in MIS-TLIF.
The digitally enabled TELIGEN VUE Camera, located at the distal end of the patient-specific port, is designed to eliminate the need for a microscope and can provide an unobstructed view of the surgical site. It offers hands-free visualization during the procedure, along with a multidirectional and expanded field of view. Additionally, the self-cleaning camera includes LED lighting and allows surgeons to manipulate image clarity based on their preference. A heads-up display allows surgeons to maintain ergonomic posture during procedures.
Based on a small cadaveric study, TELIGEN can reduce fluoroscopy time by 47% compared to MIS-TLIF procedures performed using a surgical microscope. It also provides a reduction in instrument trays and processing costs per surgery for the 10 additional trays not required with the TELIGENâ„¢ System.
DePuy Synthes was granted FDA 510(k) clearance to market the TELIGENâ„¢ System, an integrated technology platform that supports minimally invasive surgical transforaminal lumbar interbody fusion (MIS-TLIF) procedures through digital tools for visualization and access.
TELIGEN will be available in the U.S. later this year.
TELIGEN comprises a...
DePuy Synthes was granted FDA 510(k) clearance to market the TELIGENâ„¢ System, an integrated technology platform that supports minimally invasive surgical transforaminal lumbar interbody fusion (MIS-TLIF) procedures through digital tools for visualization and access.
TELIGEN will be available in the U.S. later this year.
TELIGEN comprises a tower that delivers a suite of technologies, including camera control, a VueLIF-Tâ„¢ Procedure Kit with disposable HD camera, a TELIGEN Clear Discectomy Device and patient-based disposable ports. TELIGEN integrates with the UNLEASHâ„¢ bundle of implants, which is designed to streamline the main stages in MIS-TLIF.
The digitally enabled TELIGEN VUE Camera, located at the distal end of the patient-specific port, is designed to eliminate the need for a microscope and can provide an unobstructed view of the surgical site. It offers hands-free visualization during the procedure, along with a multidirectional and expanded field of view. Additionally, the self-cleaning camera includes LED lighting and allows surgeons to manipulate image clarity based on their preference. A heads-up display allows surgeons to maintain ergonomic posture during procedures.
Based on a small cadaveric study, TELIGEN can reduce fluoroscopy time by 47% compared to MIS-TLIF procedures performed using a surgical microscope. It also provides a reduction in instrument trays and processing costs per surgery for the 10 additional trays not required with the TELIGENâ„¢ System.
Copy to clipboard 
